A novel high-affinity peptide antagonist to the insulin receptor - PubMed (original) (raw)
. 2008 Nov 14;376(2):380-3.
doi: 10.1016/j.bbrc.2008.08.151. Epub 2008 Sep 7.
Affiliations
- PMID: 18782558
- DOI: 10.1016/j.bbrc.2008.08.151
A novel high-affinity peptide antagonist to the insulin receptor
Lauge Schäffer et al. Biochem Biophys Res Commun. 2008.
Abstract
In this publication we describe a peptide insulin receptor antagonist, S661, which is a single chain peptide of 43 amino acids. The affinity of S661 for the insulin receptor is comparable to that of insulin and the selectivity for the insulin receptor versus the IGF-1 receptor is higher than that of insulin itself. S661 is also an antagonist of the insulin receptor of other species such as pig and rat, and it also has considerable affinity for hybrid insulin/IGF-1 receptors. S661 completely inhibits insulin action, both in cellular assays and in vivo in rats. A biosynthetic version called S961 which is identical to S661 except for being a C-terminal acid seems to have properties indistinguishable from those of S661. These antagonists provide a useful research tool for unraveling biochemical mechanisms involving the insulin receptor and could form the basis for treatment of hypoglycemic conditions.
Similar articles
- Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks.
Schäffer L, Brissette RE, Spetzler JC, Pillutla RC, Østergaard S, Lennick M, Brandt J, Fletcher PW, Danielsen GM, Hsiao KC, Andersen AS, Dedova O, Ribel U, Hoeg-Jensen T, Hansen PH, Blume AJ, Markussen J, Goldstein NI. Schäffer L, et al. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4435-9. doi: 10.1073/pnas.0830026100. Epub 2003 Apr 8. Proc Natl Acad Sci U S A. 2003. PMID: 12684539 Free PMC article. - pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.
Kohn WD, Micanovic R, Myers SL, Vick AM, Kahl SD, Zhang L, Strifler BA, Li S, Shang J, Beals JM, Mayer JP, DiMarchi RD. Kohn WD, et al. Peptides. 2007 Apr;28(4):935-48. doi: 10.1016/j.peptides.2007.01.012. Epub 2007 Jan 25. Peptides. 2007. PMID: 17328992 - [Regulation of insulin receptor expression and its place in the mechanism of insulin action].
Bezdrobnyĭ IuV. Bezdrobnyĭ IuV. Usp Sovrem Biol. 1981 Jul-Aug;92(1):35-48. Usp Sovrem Biol. 1981. PMID: 7027664 Review. Russian. No abstract available. - Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor.
Ward CW, Lawrence MC. Ward CW, et al. Bioessays. 2009 Apr;31(4):422-34. doi: 10.1002/bies.200800210. Bioessays. 2009. PMID: 19274663 Review.
Cited by
- Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2.
Wortham M, Ramms B, Zeng C, Benthuysen JR, Sai S, Pollow DP, Liu F, Schlichting M, Harrington AR, Liu B, Prakash TP, Pirie EC, Zhu H, Baghdasarian S, Auwerx J, Shirihai OS, Sander M. Wortham M, et al. bioRxiv [Preprint]. 2024 Feb 28:2024.02.24.581864. doi: 10.1101/2024.02.24.581864. bioRxiv. 2024. PMID: 38464227 Free PMC article. Preprint. - The liver-derived exosomes stimulate insulin gene expression in pancreatic beta cells under condition of insulin resistance.
Mahmoudi-Aznaveh A, Tavoosidana G, Najmabadi H, Azizi Z, Ardestani A. Mahmoudi-Aznaveh A, et al. Front Endocrinol (Lausanne). 2023 Nov 7;14:1303930. doi: 10.3389/fendo.2023.1303930. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027137 Free PMC article. - Endocytosis of insulin at the blood-brain barrier.
Pemberton S, Galindo DC, Schwartz MW, Banks WA, Rhea EM. Pemberton S, et al. Front Drug Deliv. 2022;2:1062366. doi: 10.3389/fddev.2022.1062366. Epub 2022 Nov 24. Front Drug Deliv. 2022. PMID: 37936681 Free PMC article. - State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer's Disease.
Rhea EM, Leclerc M, Yassine HN, Capuano AW, Tong H, Petyuk VA, Macauley SL, Fioramonti X, Carmichael O, Calon F, Arvanitakis Z. Rhea EM, et al. Aging Dis. 2024 Aug 1;15(4):1688-1725. doi: 10.14336/AD.2023.0814. Aging Dis. 2024. PMID: 37611907 Free PMC article. Review. - FGFR-mediated ERK1/2 signaling contributes to mesendoderm and definitive endoderm formation in vitro.
Lau HH, Amirruddin NS, Loo LSW, Chan JW, Iich E, Krishnan VG, Hoon S, Teo AKK. Lau HH, et al. iScience. 2023 Jul 3;26(8):107265. doi: 10.1016/j.isci.2023.107265. eCollection 2023 Aug 18. iScience. 2023. PMID: 37502260 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous